BRODSKY & SMITH INVESTOR ALERT: Updates on Investigations Involving 89bio, Inc. (Nasdaq - ETNB), Barinthus Biotherapeutics plc (Nasdaq - BRNS), Verint Systems Inc. (Nasdaq - VRNT), and Dayforce, Inc. (NYSE - DAY)
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Oct 08 2025
0mins
Source: Newsfilter
Investigation Announcements: Brodsky & Smith is reminding investors about ongoing investigations into several companies regarding potential breaches of fiduciary duties by their boards during merger agreements.
Merger Details: The investigations focus on 89bio, Barinthus Biotherapeutics, Dayforce, and Verint Systems, with concerns that the deal considerations may not provide fair value to shareholders, particularly as some offers are below the companies' 52-week highs.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
